All Type of News
Illegal rebate offenders increased 11 times more
Illegal drug rebates have been active again for the past 3 years as there are 11 times more illegal acts of providing illegal rebates and the amount of illegal bribery got double.
According to a report the Ministry o...
Rapid increase of illegal rebates for past 3 years in various methods
While illegal drug rebates were rapidly increased for the past 3 years, there were also 16 companies exposed for illegal rebates for more than 3 times.
The highest number of times a single company was exposed for ill...
32 of 117 legal communicable diseases controlled by government have no treatment
Among the total 117 legal communicable diseases which are controlled by each the Emergency Center, Communicable Control Center and Disease Prevention Center, 32 of them have no treatment.
Liberty Korea Rep. Sang-Hoon...
Rush of patients to hospitals in capital area only for ‘minor illness’
With a widened gap of medical services among regions, a rush of patients to the capital area is reportedly increase every year.
According to data Justice Party Rep. So-Ha Yoon received from the National Health Insura...
Complera challenges HIV market again with health insurance benefits
Janssen Korea’s HIV treatment ‘Complera’ attracted the industry as returning the market with health insurance benefits.
The Ministry of Health and Welfare(MOHW) revised and announced health insurance registration of ...
3 of 4 approved medicines were ETC
3 of 4 approved medicines were reportedly a ETC drug.
According to the Ministry of Food and Drug Safety, there were total 1,497 medicine products approved between January and September; among the total, 1,196 product...
SK Chemicals acquires commercialization approval of world’s 2nd zoster vaccine ‘Sky Zoster’
A Korean pharmaceutical company is expected to widen options for patients using its excellent technology power in the world’s zoster vaccine market which has been monopolized by a global pharmaceutical company.
SK Ch...
“We recommend Metformin as primary treatment for oral drug of diabetes type II”
It was suggested ‘Metformin’ must be primarily used as an oral single-substance drug for the treatment of diabetes type II.
The Korean Diabetes Association(Chairman Moon-Gyu Lee), on the 28th, held a press conference...
Prolia enters range of health insurance benefits based on excellent bone density improvement
‘Prolia(generic name: denosumab),’ an Amgen Korea’s first biological osteoporosis treatment, has been registered in the health insurance benefit list since the 1st of October.
Prolia, the first and only osteoporosis ...
Revision bill to Pharmaceutical Affairs Law passed National Assembly plenary session
Various alternatives, such as revocation of pharmacist license for mental illness patients, integration of bioequivalence test and clinical trials and indication of every substance and ingredient on quasi drugs, passe...
